Anemia

Amgen recalls anemia drugs due to glass flakes

Amgen 2Q net income slips on higher taxes

Affymax shares plunge on drug safety concerns

Affymax receives $5M payment for drug development

FDA: Amgen, J&J must discuss anemia drug risks

TRENTON, N.J. - Amgen Inc.

MORE..

NEW YORK - Biotechnology company Amgen Inc.

MORE..

NEW YORK - Shares of Affymax Inc.

MORE..

PALO ALTO, Calif. - Biotechnology company Affymax Inc.

MORE..

Older News

WASHINGTON - Amgen and Johnson & Johnson will be required to publicize the life-threatening risks of their anemia drugs, under the latest government-imposed safety precautions to snare the blockbuster biotech drugs.

MORE..

More News

Amgen 4Q profit rises 1 percent with sales steady
Amgen shares dip on anemia drug concerns
Amgen says court blocks rival Roche anemia drug